PhiloMetron

Philo Metron

Medical Devices, 4940 Carroll Cyn Rd, San Diego, California, 92121, United States, 1-10 Employees

philometron.com

  • LinkedIn

phone no Phone Number: +18*********

Who is PHILOMETRON

PhiloMetron, Inc., is a medical technology accelerator focused on developing therapeutic management systems for large unmet quality of life and healthcare needs. PhiloMetron creates a sep...

Read More

map
  • 4940 Carroll Cyn Rd, San Diego, California, 92121, United States Headquarters: 4940 Carroll Cyn Rd, San Diego, California, 92121, United States
  • 2001 Date Founded: 2001
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 7352 | NAICS Code: 532291 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PHILOMETRON

PhiloMetron Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding PhiloMetron

Answer: PhiloMetron's headquarters are located at 4940 Carroll Cyn Rd, San Diego, California, 92121, United States

Answer: PhiloMetron's phone number is +18*********

Answer: PhiloMetron's official website is https://philometron.com

Answer: PhiloMetron's revenue is $5 Million to $10 Million

Answer: PhiloMetron's SIC: 7352

Answer: PhiloMetron's NAICS: 532291

Answer: PhiloMetron has 1-10 employees

Answer: PhiloMetron is in Medical Devices

Answer: PhiloMetron contact info: Phone number: +18********* Website: https://philometron.com

Answer: PhiloMetron, Inc., is a medical technology accelerator focused on developing therapeutic management systems for large unmet quality of life and healthcare needs. PhiloMetron creates a separate legal entity - "spinout" - at key valuation and technology readiness points of clinical development. PhiloMetron's first spinout, Corventis, Inc., is focused solving numerous cardiovascular unmet needs and is funded by Kleiner, Perkins, Caufield & Byers, Mohr-Davidow Ventures and DAG Ventures. Sapphire Therapy Inc is PhiloMetron's second spinout and is developing the novel stenosis management system that improves patency and reduces the cost of vascular graft maintenance. . PhiloMetron's third spinout is developing a novel platform to improve metabolic management in consumer and clinical applications.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access